BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36012557)

  • 1. Deletion of Macrophage-Specific Glycogen Synthase Kinase (GSK)-3α Promotes Atherosclerotic Regression in
    Patel S; Mastrogiacomo L; Fulmer M; Shi Y; Werstuck GH
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice.
    Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH
    Am J Pathol; 2014 Dec; 184(12):3394-404. PubMed ID: 25451156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the Role of Glycogen Synthase Kinase-3α/β in Macrophage Polarization and the Regulation of Pro-Atherogenic Pathways in Cultured Ldlr
    Patel S; Werstuck G
    Front Immunol; 2021; 12():676752. PubMed ID: 34394077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Myeloid GSK3α Attenuates Atherosclerosis and Promotes an M2 Macrophage Phenotype.
    McAlpine CS; Huang A; Emdin A; Banko NS; Beriault DR; Shi Y; Werstuck GH
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1113-22. PubMed ID: 25767272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques.
    Huang A; Young TL; Dang VT; Shi Y; McAlpine CS; Werstuck GH
    Atherosclerosis; 2017 Nov; 266():103-112. PubMed ID: 29024862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the Role of Endothelial Glycogen Synthase Kinase3α/β in Atherogenesis in Low Density Lipoprotein Receptor Knockout Mice.
    Mastrogiacomo L; Werstuck GH
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase R-like endoplasmic reticulum kinase and glycogen synthase kinase-3α/β regulate foam cell formation.
    McAlpine CS; Werstuck GH
    J Lipid Res; 2014 Nov; 55(11):2320-33. PubMed ID: 25183803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
    Wang F; Liu Z; Park SH; Gwag T; Lu W; Ma M; Sui Y; Zhou C
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1468-1478. PubMed ID: 29724817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice.
    Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA
    PLoS One; 2015; 10(6):e0128996. PubMed ID: 26046657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT2 decreases atherosclerotic plaque formation in low-density lipoprotein receptor-deficient mice by modulating macrophage polarization.
    Zhang B; Ma Y; Xiang C
    Biomed Pharmacother; 2018 Jan; 97():1238-1242. PubMed ID: 29145149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis-inactivated Δ6-fatty acid desaturase-deficient mouse.
    Stoffel W; Binczek E; Schmidt-Soltau I; Brodesser S; Wegner I
    Mol Metab; 2021 Dec; 54():101335. PubMed ID: 34530175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced calcification and osteogenic features in advanced atherosclerotic plaques of mice with macrophage-specific loss of TRPC3.
    Dube PR; Chikkamenahalli LL; Birnbaumer L; Vazquez G
    Atherosclerosis; 2018 Mar; 270():199-204. PubMed ID: 29290366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis.
    Doddapattar P; Dev R; Ghatge M; Patel RB; Jain M; Dhanesha N; Lentz SR; Chauhan AK
    Circ Res; 2022 Apr; 130(9):1289-1305. PubMed ID: 35400205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.